Her-2/Neu in Patients With Metastatic Breast Cancer (AdHERe)
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer
Interventions: BIOLOGICAL: AdHer-2/neu transduced dendritic cells
Sponsor: Ontario Clinical Oncology Group (OCOG)
Collaborators: Ontario Cancer Research Network|Canadian Breast Cancer Research Alliance